Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme.

Research Grants 254 show all


$55.2M
2015

$91.1M
2016

$135.4M
2017

$55.1M
2018

$18M
2019

Publications 58 show all

  • 8
    Viral Vaccines/immunology
  • 5
    Flavivirus/immunology
  • 5
    Viral Vaccines/adverse effects
  • 5
    West Nile virus/immunology
  • 5
    Yellow Fever Vaccine/immunology
  • 5
    Yellow fever virus/genetics
  • 4
    Yellow Fever Vaccine/therapeutic use
  • 4
    Yellow Fever/prevention & control
  • 4
    Yellow fever virus/immunology
  • 3
    Dengue Virus/genetics

Patents 172,899show all

  • 23,442
    C07D - Heterocyclic compounds
  • 14,742
    C07C - Acyclic or carbocyclic compounds
  • 12,872
    A61K - Preparations for medical, dental, or toilet purposes
  • 6,572
    C09B - Organic dyes or closely-related compounds for producing dyes
  • 5,561
    C07K - Peptides
  • 5,349
    C08F - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
  • 4,774
    C07F - Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
  • 4,734
    A61M - Devices for introducing media into, or onto, the body
  • 4,475
    C08G - Macromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds
  • 3,352
    D06P - Dyeing or printing textiles

Clinical Trials 3,691show all

1,025Phase 3774Phase 2629N/A503Phase 4368Phase 1191Other

Contact Information

Paris
France